Ryan J. Watts - President and CEO, Director at Denali Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
DNLI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Ryan J. Watts - trading volume in the past year for Denali Therapeutics Inc.

Holdings reported by Ryan J. Watts for Denali Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 2,202,604 $45.2 M $20.50 Mar 29, 2024 Indirect
Common Stock 238,067 $4.88 M $20.50 Mar 29, 2024 Direct
Stock Option (right to buy) 268,560 Jan 3, 2024 Direct Common Stock

Transactions reported by Ryan J. Watts for Denali Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership